Aminosalicylate Sodium

We are Aminosalicylate Sodium CAS:133-10-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Name: Aminosalicylate Sodium
Other Name:
Sodium 4-amino-2-hydroxybenzoate;
Sodium 4-Aminosalicylate;
p-Aminosalicylic acid sodium salt;
4-Amino-2-hydroxybenzoic acid sodium salt;
p-Aminosalicylate sodium;
Monosodium 4-amino-2-hydroxybenzoate;
p-Aminosalicylic Acid Monosodium Salt;
CAS No: 133-10-8
MF: C7H6NNaO3
MW: 175.117
Density: 1.491g/cm3
Boiling point: 380.8ºC at 760 mmHg
Melting point: 150-151ºC, with effervescence
Flash point: 184.1ºC
UN Number: N/A
UN Proper Shipping Name: N/A
Transport hazard class: N/A
Packing group: N/A
 
Specification
Appearance: White or off-white crystalline powder
Purity(HPLC): ≥98.5%
Color: ≤B5
pH: 6.5-8.5
M-Aminophenol: ≤0.1%
5-Aminosalicylic acid: ≤1.0%
Single impurity: ≤0.1%
Total impurity: ≤1.0%
Heavy metal: ≤10ppm
Loss on drying: 16.0-17.5%
Assay: 90.0-101.0%
 
Application
Anti-tuberculosis drugs, mainly used for comprehensive treatment of various tuberculosis infections.
 
Package: 25kg/drum, can also be designed according to customer requirements.
Storage: Store in cool place. Keep container tightly closed in a dry and well-ventilated place.

Aminosalicylate Sodium


Related News: What is the difference? Raw material refers to chemical compounds that are used as a base to make an API.50606-58-1 The oral form of rigosertib was developed to provide a potentially more convenient dosage form for use where the duration of treatment may extend to multiple years.351-50-8 With the speeding up of review and approval, the number of approved innovative drugs in China is about to usher in a year of blowout.3-Bromo-4-fluorobenzotrifluoride In recent years, China’s bulk drug companies have gradually completed the upgrade of the product structure of bulk raw materials to specialty raw materials and intermediates. The industry’s leading companies have further developed the research and development layout of high-barrier generic pharmaceutical raw materials with multiple patents that have not yet expired.With the global industrial division of labor and the change in the business model of multinational pharmaceutical companies, the outsourced market for patented drug substances will further expand.

Related Products
Product Name
N-(2,6-Dimethylphenyl)chloroacetamide View Details
2-chloro-4-methyl-3-nitropyridine View Details
2-chloro-4-isothiocyanatobenzonitrile View Details
(2-Methoxynaphthalen-1-yl)boronic acid manufacturer 2-(1H-1,2,4-Triazol-1-yl)-2′,4′-difluoroacetophenone manufacturer 3,5-DI-O-(P-TOLUYL)-2-DEOXY-D-RIBOFURANOSYL CHLORIDE manufacturer 2-Bromotriphenylamine manufacturer 1,2,4-trichlorobenzene manufacturer